Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Capital Employed (2022 - 2026)

HeartSciences (HSCS) has disclosed Return on Capital Employed for 4 consecutive years, with 1.77% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 18.0% year-over-year to 1.77%, compared with a TTM value of 1.77% through Oct 2025, down 18.0%, and an annual FY2025 reading of 2.64%, down 129.0% over the prior year.
  • Return on Capital Employed was 1.77% for Q4 2025 at HeartSciences, up from 3.52% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 5.54% in Q4 2023 and bottomed at 6.63% in Q2 2025.
  • Average Return on Capital Employed over 4 years is 2.27%, with a median of 2.51% recorded in 2022.
  • The sharpest move saw Return on Capital Employed skyrocketed 864bps in 2023, then crashed -714bps in 2024.
  • Year by year, Return on Capital Employed stood at 3.09% in 2022, then surged by 279bps to 5.54% in 2023, then plummeted by -129bps to 1.59% in 2024, then fell by -11bps to 1.77% in 2025.
  • Business Quant data shows Return on Capital Employed for HSCS at 1.77% in Q4 2025, 3.52% in Q3 2025, and 6.63% in Q2 2025.